Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / ISIN
-
Number of holders
-
207
-
Total shares
-
84.9M
-
Shares change
-
+8.84M
-
Total reported value, excl. options
-
$649M
-
Value change
-
+$65.4M
-
Put/Call ratio
-
0.54
-
Number of buys
-
89
-
Number of sells
-
-66
-
Price
-
$7.63
Significant Holders of SORRENTO THERAPEUTICS INC - ISIN (SRNE) as of Q3 2021
218 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - ISIN as of Q3 2021.
SORRENTO THERAPEUTICS INC - ISIN (SRNE) has 207 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 84.9M shares
.
Largest 10 shareholders include BlackRock Inc. (20.9M shares), VANGUARD GROUP INC (15.5M shares), STATE STREET CORP (12.3M shares), GEODE CAPITAL MANAGEMENT, LLC (5.06M shares), D. E. Shaw & Co., Inc. (2.95M shares), JPMORGAN CHASE & CO (2.94M shares), NORTHERN TRUST CORP (2.92M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (2.03M shares), SABBY MANAGEMENT, LLC (1.7M shares), and Nuveen Asset Management, LLC (1.09M shares).
This table shows the top 207 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.